APC and breast cancer: The methylated promoters of tumor suppressor genes, adenomatous polyposis coli (APC), and retinoic acid receptors-β2 (RARβ2) were observed in 93.4% and 95.6% of serum samples, respectively, from breast cancer patients, but were not detected in healthy subjects.